Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Teaching healthcare workers about emergency virus protection: will it stick?

NCT ID NCT07330427

Knowledge-focused Sponsor: Aswan University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study at Aswan University Hospital in Egypt will give 340 healthcare workers special training on post-exposure prophylaxis (PEP) — the steps to take right after accidental contact with blood or body fluids that might carry HIV, hepatitis B, or hepatitis C. Researchers will measure the workers' knowledge, attitudes, and practices before and after the training to see if education makes a difference. The goal is to improve how well healthcare workers protect themselves after an on-the-job exposure.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Health education sessions
What this could lead to
If successful, this could show that simple education programs help healthcare workers better protect themselves after accidental exposure to blood-borne viruses.
What could go wrong
This is a small, single-hospital study measuring knowledge changes, not actual infection rates. Results may not apply to other settings, and improved knowledge doesn't always change real-world behavior.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 340 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jun 2025

Expected to finish

Feb 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 55 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. HCWs at the selected departments (physicians, nurses and housekeepers). 2. Age \>18 years old and below 60 years old in both Genders. 3. HCWs which have direct contact with blood and body fluids. Exclusion Criteria: 1. Age\<18 years old and above 60 years old. 2. Non-medical staff at Aswan university hospital. 3. Health care workers which have no contact with blood or body fluids.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post-exposure prophylaxis are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post-exposure prophylaxis

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Aswan faculty of Medicine

    RECRUITING

    Aswān, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.